Candriam SCA’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-142,745
Closed -$2.16M 903
2022
Q3
$2.16M Buy
+142,745
New +$2.16M 0.02% 566
2022
Q1
Sell
-151,000
Closed -$1.06M 860
2021
Q4
$1.06M Buy
+151,000
New +$1.06M 0.01% 643
2021
Q2
Sell
-576,495
Closed -$7.48M 947
2021
Q1
$7.48M Hold
576,495
0.06% 306
2020
Q4
$7.79M Sell
576,495
-15,305
-3% -$207K 0.06% 314
2020
Q3
$6.97M Hold
591,800
0.07% 295
2020
Q2
$8.74M Sell
591,800
-78,000
-12% -$1.15M 0.09% 236
2020
Q1
$15.8M Hold
669,800
0.18% 136
2019
Q4
$16.2M Sell
669,800
-30,000
-4% -$725K 0.17% 136
2019
Q3
$13.5M Buy
699,800
+95,000
+16% +$1.83M 0.18% 133
2019
Q2
$17.8M Hold
604,800
0.22% 103
2019
Q1
$28.7M Buy
604,800
+126,000
+26% +$5.99M 0.37% 50
2018
Q4
$17.3M Buy
478,800
+152,000
+47% +$5.49M 0.27% 80
2018
Q3
$20.1M Buy
326,800
+205,100
+169% +$12.6M 0.27% 86
2018
Q2
$8.22M Buy
121,700
+42,700
+54% +$2.88M 0.13% 199
2018
Q1
$4.29M Buy
79,000
+7,000
+10% +$380K 0.07% 316
2017
Q4
$4.3M Buy
72,000
+13,000
+22% +$777K 0.07% 294
2017
Q3
$2.87M Buy
59,000
+19,000
+48% +$923K 0.05% 379
2017
Q2
$2.1M Buy
40,000
+10,000
+33% +$526K 0.04% 453
2017
Q1
$1.36M Sell
30,000
-4,000
-12% -$181K 0.03% 514
2016
Q4
$1.29M Hold
34,000
0.03% 469
2016
Q3
$1.28M Buy
+34,000
New +$1.28M 0.03% 447
2015
Q2
Sell
-243,000
Closed -$7.62M 670
2015
Q1
$7.62M Sell
243,000
-67,000
-22% -$2.1M 0.15% 181
2014
Q4
$9.05M Buy
+310,000
New +$9.05M 0.19% 158